# FDA recall D-0300-2026

> **NOVADOZ PHARMACEUTICALS LLC** · Class III · drug recall initiated 2025-12-15.

## Product

Glycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc., Piscataway, NJ 08854, Distributed by: Novadoz Pharmaceuticals LLC, Piscataway, NJ 08854, NDC 72205-070-72

## Reason for recall

Failed Impurities/Degradation Specifications

## Distribution

US Nationwide.

## Key facts

- **Recall number:** D-0300-2026
- **Recalling firm:** NOVADOZ PHARMACEUTICALS LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2025-12-15
- **Report date:** 2026-02-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Piscataway, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0300-2026

## Citation

> AI Analytics. FDA recall D-0300-2026. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0300-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*